ACHE and early-onset autosomal dominant Alzheimer disease: Another study proposed that Soyasapogenol B showed promise as a natural inhibitor of AChE (Figure 2) and BuChE (Figure 3, with favorable physicochemical qualities, binding stability, and safety profile, indicating its potential for treating neurodegenerative illnesses such as Alzheimer’s disease [227].